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To identify cell surface molecules that define position in the mammalian nervous system, we previously characterized the binding of two monoclonal antibodies, ROCAl and ROCAP, to adult rat sympathetic ganglia and intercostal nerves. The binding of ROCAl is highest in rostra1 ganglia and nerves and declines in a graded manner in the caudal segments. ROCAP labels the same cells in ganglia and nerves as ROCAl, but not in a position-selective manner. We now show by immunoblot analysis that ROCAl recognizes two antigens in membranelcytoskeletal fractions of peripheral nerves and ganglia:
(1) a Triton X-lOO-insoluble, 60 kDa protein and (2) It is thought that positional information at the cellular level plays a key role in pattern formation (Wolpert, 1989) . The molecular mechanisms underlying the specification of positional information have been studied in Drosophila and mice. Homeotic selector gene expression, for instance, specifies segmental Received Sept. 18, 1992; revised Dec. 10, 1992; accepted Dec. IS, 1992 . We thank Dr. Linda M. Parysek for the anti-peripherin antiserum and the peripherin fusion protein, and for helpful suggestions regarding their use; Dr.
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Portier for the reference to unpublished data; Danny Chu and Shubha Tole for the micrographs presented in Figure 6 ; Arash Bashirullah for assistance in figure preparation (Lewis, 1963 (Lewis, , 1978 NussleinVolhard and Wieschaus, 1980) , and is restricted to particular domains along the anterior-posterior axis of the mouse embryo in the brain and spinal cord, and in many mesoderm-derived tissues (Holland and Hogan, 1988; Kessel and Gruss, 1990; McGinnis and Krumlauf, 1992) . The anterior-posterior expression boundaries of these genes correlate with their relative 3'-5' positions on the chromosomes ofboth Drosophila and mice (Akam, 1989; Duboule and Dolle, 1989; Graham et al., 1989) . Molecular analyses have shown that the transcription factors cncodcd by many of these genes regulate the specification of positional information by an array of hierarchical and combinatorial interactions (Ingham, 1988) . Mutations in the homeotic genes affect regional specification in both Drosophila and mice (Nusslein-Volhard and Wieschaus, 1980; Chisaka and Capecchi, 1991; Mouellic et al., 1992) , and can lead to alterations in the pathways ofaxonal growth (Doe et al., 1988; Lufkin et al., 1991; Chisaka et al., 1992) . The latter results suggest that the spccification of neuronal connections may be based, in part, on the downstream products of the homeotic genes. While these genes regulate segmental identity, they encode DNA-binding proteins localized to the cell nucleus, and thus are not able to convey positional information directly to neighboring cells. It seems likely that these positional regulators activate target genes in a cascade, leading to the expression of particular cell surface and secreted proteins that influence intercellular interactions. The identification ofdownstrcam targets of homcotic gene control has only recently begun (Gould et al., 1990; Immergluck et al., 1990; Reuter et al., 1990; St. Johnston et al., 1990) . The neural cell adhesion molecule (NCAM) has a homeodomain binding site in its promoter region (Hirsch et al., 1991) , and HOX 2.5 and 2.4 can modulate transcription from this promoter (Jones et al., 1992) .
Additional candidates for surface molecules that may supply positional information in the vertebrate nervous system are those whose distribution reflects particular patterns of synaptic connections. Considerable attention has focused on the retinotectal system, where Sperry's chemoaffinity hypothesis postulates that the specificity of connections is established through matching biochemical differences among cells in the retina with corresponding differences among cells in the tectum (Sperry, 1963) . A number of cell surface proteins display intriguing patterns of expression in this regard. TRAP (temporal retinal axon protein) is asymmetrically distributed in the nasal-temporal axis of the retina (McLoon, 199 l) , the TOP,, and TOP,, proteins arc distributed in dorsoventral and anteroposterior topographic gradients in both retina and tectum (Trisler, 1990) , and a 33 kDa membrane glycoprotein is enriched in the posterior tectum . Moreover, an antiserum raised against pos-terior membranes that recognizes the 33 kDa protein abolishes both the ability of these membranes to collapse retina1 growth cones and to specifically inhibit temporal retinal axon growth . Thus, this protein may be responsible for the preferential growth of temporal retina1 axons on anterior membranes, through its ability to specifically inhibit or repulse temporal growth cones (Walter et al., 1987 (Walter et al., , 1990 Muller et al., 1990) . In addition, an isoform ofaldehyde dehydrogenase (AHD-2) is present at much higher levels in the dorsal as compared to the ventral retina (McCaffery et al., 1991) . Since AHD-2 oxidizes retinaldehyde to retinoic acid (Lee et al., 199 I) , and recent results have demonstrated asymmetrical rctinoic acid synthesis along the dorsovcntral axis ofthc retina (McCaffery et al., 1992) , it seems possible that retinoic acid plays a role in the specilication of positional information in this system.
Cell surface epitopes are asymmetrically distributed within the retinotectal system, as well. For example, the JONES carbohydrate cpitope present on several gangliosides (Schlosshauer et al., 1988 ) is distributed in a strong dorsoventral gradient in the developing retina (Constantine-Paton et al., 1986; Rcinhardt-Maelickc et al., 1990) . Multiple monoclonal antibodies (mAbs) specific for a 43 kDa protein involved in protein translation identify a dorsoventral asymmetry in the embryonic retina (McCaffery et al., 1990; Rabacchi et al., 1990) . Despite the pronounced immunohistochemical gradient displayed by the binding of these mAbs, however, the 43 kDa protein itself is not asymmetrically distributed. Rather, the differential binding appears to be due to a difference in conformation or accessibility; the 43 kDa protein is more labile to protcolysis in the dorsal retina, and the epitopes in the ventral retina can be exposed by an appropriate fixation protocol (McCaffery et al., 1990; Rabacchi et al., 1990) .
The connections between preganglionic neurons in the spinal cord and postganglionic sympathetic neurons also form a highly stereotyped pattern, with a rostrocaudal gradient of specificity (Langley, 1892 (Langley, , 1895 Purves and Lichtman, 1978) . Moreover, transplantation experiments in this system suggest that neurons and muscles may share cell surface molecules that define rostrocaudal position (Purves et al., 198 1; Sanes, 1982, 1985) . Two experimental paradigms have identified molecules that are of interest in this regard. A > lOO-fold rostrocaudal gradient of CAT levels is detected in muscles of adult mice bearing a myosin light chain I (MLCl)-CAT transgenc (Donoghue et al., 199 1) . In these mice, muscle rostrocaudal position determines the level of CAT that it expresses, with caudal muscles expressing the highest levels. Since there is no gradient of endogenous MLCl expression, it is suggested that the MLCl gene contains elements responsive to a positionally graded signal that is masked or normally inactive (Donoghue et al., 1991) . This notion is consistent with the existence of endogenous regulators of position in targets of spinal motor neurons.
Other potential candidates for the specification of positional information in this system have been identified through a mAb approach. Immunohistochemical staining with one of these mAbs, ROCAI (ROstroCAudal), is highest in rostra1 sympathetic ganglia and intercostal nerves, and declines in a graded manner in the caudal segments (Suzuc ct al., 1990) . The ROCAl antigen was identified as a 65 kDa protein that is enriched in rostra1 intercostal nerves (Suzue et al., 1990) and, based on its distribution, is a potential downstream product of the homeotic selector genes (Suzue et al., 1990) . We here identify this antigen as a cytoskeletal component, and present evidence that ROCA I binds a 26 kDa surface membrane protein as well. Surprisingly, this surface protein is also recognized by another mAb, ROCAZ, that does not define rostrocaudal gradients. This indicates that it is the ROCAI epitope on the 26 kDa protein, and not the protein itself, that is preferentially visualized immunohistochemically in rostra1 nerves and ganglia. Thus, the ROCAl epitopc itself appears to bc a key indicator of position, as it defines rostrocaudal gradients associated with two different proteins.
Materials and Methods

Antibodies
KOCAl and ROCAZ are both lgG2b mouse mAbs. The production and initial characterization of these antibodies have been previously described (Suzue at al., 1990) . The ROCAI and KOCAZ hybridomas have been repeatedly subcloned. Each ROCA I subclone recognizes both the 60 kDa (peripherin) and the 26 kDa (rat CD9 homolog) proteins, while every ROCAZ subclone is specific for the 26 kDa protein. Large amounts of purified ROCAI antibody were obtained from hybridoma supematant through the use of the mAb Trap-G kit (Pharmacia). The anti-peripherin antiserum (199-2) was produced in a rabbit as previously described (Brody et al., 1989) . Anti-MBP is an IgG I mouse mAb specific for myelin basic protein (Boehringer Mannheim). Anti-NF-M is an IgG I mouse mAb (clone NN 18) specific for intermediate-size neurolilaments (I 60 kDa) (Sigma Immunochemicals).
Protein preparations
Mcmbrane/cytoskeletaI fractions. Tissues were immediately dissected from rats killed by asphyxiation with carbon dioxide, and immediately froxen on dry ice. Upon thawing, tissues were homogenized either by hand or by a Polytron (Brinkman Instruments Co.) in homogenization buffer (50 mM Tris-HCI (pH 7.4), 50 mM NaCI, 5 mM EDTA, 2 mM EGTA) containing five protease inhibitors: I mM phenylmethylsulfonyl lluoride, 20 rg/ml aprotinin, 20 &ml turkey egg white trypsin inhibitor, 2 mM benzamidine, and 5 mM N-ethylmaleimide.
The homogenates were first centrifuged at 1000 rpm for 10 min in an IEC HN-SII tablctop centrifuge lo pellet nuclei and cell debris. The resulting supematants were next centrifuged at 6000 x g for I5 min in a Sorvall SS 34 rotor to remove mitochondria and any remaining cell debris. The supematants were centrifuged at 100,000 x g for 1 hr in a Beckman 70 Ti rotor. The pellets were resuspended in homogenization buffer and washed twice by centrifugation at 100,000 x g for 1 hr and subsequent resuspension. The final pellets were resuspended in homogenization buffer. This material, which will be referred to as the mcmbrane/cytoskeletaI fraction. was cithcr used immediately or frozen at -80°C: until further USC. All procedures were carried out at 4°C. Protein concentration was determined by the method of Lowry et al. (195 I) .
Triton X-lOO-soluble and -inwluble fractions. Membrane/cytoskelctal fractions were rccentrifuged at 100,000 x g for 1 hr in a Beckman 70 Ti rotor. The pellets were thoroughly resuspended by homogenization in homogenization buffer containing 1% Triton X-100, and again centrifugcd at 100,000 x g for I hr. The resulting supernatants are referred lo as the Triton X-1 OO-soluble fractions, and the pellets, resuspended in homogenization buffer without detergent, arc referred to as the Triton X-IOO-insoluble fractions. (Gorham et al., 1990) . The extraction of the hybrid protein was performed as described in Koemer et al. (199 I) .
Immunoprecipitution Triton X-1 00-solubilized fractions ofadult rat sciatic nerves were mixed (I: I) with ROCAI hybridoma supematant and rotated end-over-end for 12-l 6 hr at 4°C. After this incubation, 50 ~1 of Protein G-Sepharose beads (Sigma) wcrc added to the mixture and the incubation was continucd for another 3 hr at room temperature. The beads were then centrifuged in a microfuge, the supematant was removed, and the beads were washed three times in Tris-buflered saline (TBS: 0.9% NaCI. 20 mM Tris-HCl, pH 7.4) containing 0.5% Tween-20 by a series of resuspensions and centrifugations. After a linal wash in TBS without detergent, the beads were placed in 1 x nonreducing sample bufler (see below) for 5 min to elute bound antigens.
AJinity purification
Adult rat peripheral nerve (including sciatic nerve and brachial plexus) membrane/cytoskeletaI fractions derived from about 5-l 0 gm of nerves were solubilized with I% NP-40. These extracts were then frozen, thawed, clarified by centrifugation at 100,000 x I: for 1 hr in a Beckman 70 Ti rotor, and diluted to 0.5% NP-40. This preparation was then incubated end-over-end for 12-16 hr at 4°C with Protein G-Sepharosc beads, to which 6 mg/ml of purified ROCAI mAb had been coupled and crosslinked with 50 mM dimethyl pimelimidate (Pierce) according to Schneider et al. (1982) . After the incubation, the beads wcrt' placed in a small column, washed with live column volumes of homogenization bulTer containing 0.5% NP-40, and linally washed with 1 column volume of homogenization buffer without detergent. The antigen(s) was eluted with 2 column volumes (in 0.2 column volume fractions) of 0. I h4 glycinc-HCI (pH 2.7) containing 0.5% NP-40. Fractions were neutralized immediately with I M Tris-HCI (pH 9.0) (60 ~1 per 1 ml fraction). Fractions containing the 26 kDa protein were identified by silver staining or immunoblot analysis of proteins separated by SDS-PAGE.
Electrophoresis
O~dimensionul. SDS-PAGE was performed as described by Laemmli (I 970) in I .5-mm-thick, 10% polyacrylamide slab gels. All samples were diluted I: I with 2 x nonreducing sample buffer 120% glycerol, 4Yo SDS, 0. I3 M Tris, 0.01 mg/ml bromophenol blue (pH 6.8)] prior to loading. Two-dimensionul. Two-dimensional gel electrophoresis was performed according to O'Farrell (I 975) . The lirst (horizontal) dimension isoelectric focusing gels were run in a Mighty Small II (SE 250) apparatus using 0.75-mm-diameter tube gels, with 0.2% ampholines (pH 4.5-5.4; Pharmalyte, Sigma), according to the instructions provided by the manufacturer (Hoeffer Scientific Instruments). The proteins in the tube gels were further resolved in the second (vertical) dimension by SDS-PAGE (Laemmli, 1970), on I.5 mm, 10% polyacrylamidc slab gels.
Pro&in staining. For detection of proteins by Coomassie blue, oneand two-dimensional gels were incubated in 0. I% Coomassie blue R-250, 50% methanol, and 1 O%glacial acetic acid for 2 hr at room temperature. The gels were destained over 2-4 hr with multiple changes ofa solution containing 5% methanol and 10% glacial acetic acid. For detection of proteins by silver staining, a protocol similar to the one described in Oakley et al. (I 980) was employed. One-and two-dimensional gels were lixed in 50% methanol, 10% glacial acetic acid for 30 min; rinsed twice in 10% ethanol, 5% glacial acetic acid for 10 min each and once in distilled water(dH,O) for IO min; sensitized for 30 min in 0.2 M NaHCO, containing 1% glutaraldehyde; rinsed twice in dH,O for 10 min each; stained for I hr in 0.2% silver nitrate, 0.075% sodium hydroxide, 0.42Oh ammonium hydroxide; and developed by treatment with 0.005% citric acid, 0.009% formaldehyde for 5-l 0 min. The reaction was terminated by rinsing the gels in multiple changes of dH,O over I hr. All steps described above were carried out with mild agitation. Gels were dried using a Bio-Rad slab gel dryer (model 583).
Immunoblotting
Following SDS-PAGE, one-and two-dimensional gels were equilibrated for 15 min in transfer buffer [ 12.5 mM Tris, 96 mM glycine (pH 8.5), 20% methanol], and the proteins within the gels were transferred to nitrocellulose (0.45 pm, BA85, Schleicher and Schuell) for 12-l 6 hr at 60 V in a Mighty Small Transphor unit (Hoeffer Scientific Instruments, TE 22). After transfer, the nitroccllulosc was incubated in 0.5% Ponceau-S (solid, Sigma) and 1% glacial acetic acid for 5 min, to visualize the transferred proteins. Destaining of the nitroccllulose was carried out over I5 min with multiple changes of TBS containing 0.05% Tween-20 (TBST). The nitrocellulose was then blocked in TBS containing 5% nonfat dry milk (Carnation) for 30 min at room temperature, followed by three washes over I5 min in TBST. Incubation of individual nitrockllulose strips was for either 3 hr at room temperature or 12-16 hr at 4°C. with the followinp. antibodies: ROCAI and ROCAZ (undiluted hybiidoma supematanis), or anti-NF-M (1:2000), anti-MBP (1:500), and anti-periphcrin antisera (I :2000), each diluted in TBS containing 5% dry milk. The nitroccllulose filters wcrc then washed three times over I5 min in TBST. and those reacted with ROCAI. ROCAZ. anti-MBP, or anti-NF-M were incubated with goat anti-m&x al&y-purilied antisera conjugated to pcroxidase (Chcmicon, Int.) diluted I:500 in TBS containing 5% nonfat dry milk for I hr at room temperature. The filters reacted with the anti-periphcrin antiserum were incubated with goat anti-rabbit affinity-purified antisera conjugated to peroxidasc (Bochringer Mannheim) diluted I:500 in TBS containing 5% nonfat dry milk for I hr at room temperature. After this tinal incubation, the strips were washed twice in TBST over I5 min and then once in TBS for 5 min. lmmunoreactivity was developed with 0.5 mg/ml 4-chloro-lnaphthol in 0.02% hydrogen peroxide for 2-l 5 min at room tempcraturc. The reaction was terminated with multiple washes in dH,O. After air drying, the nitrocellulose lilters were subjected to densitometric scanning using an Ultroscan XL (LKB).
In Figure 7b . the plots generated from densitometric scanning include data from two fewer immunoblots than the ones in Figure 7~ . In these two immunoblots, the NF-M:MBP ratio was significantly less than one. Since in 10 other blots the NF-M:MBP ratio was quite close to one, we did not consider thcsc two results to bc representative, and hcncc eliminated this data from the analysis.
N-terminul amino acid sequence determinution
About 2-5 pg of ROCA I -alTinity-purified peripheral nerve proteins were subjected to SDS-PAGE and transferred to ai Immobilon-P membrane (PVDF. 0.45 urn. Millinore). usinr the conditions described for transfer io nitrocellul&c. The fi'lter 'ias then rinsed in dH,O for 5 min, stained with 0.1% Coomassie blue R-250 in 50% methanol (HPLC grade, Burdick and Jackson), 10% glacial acetic acid (aldchyde free, Baker) for 5 min. and then destained in 5OYo methanol (HPLC grade), 10% glacial acetic acid (aldehyde free) for 5-10 min at room temperature. After a final rinse in dH,O for 5-10 min. a small piece of membrane containing only the 26 kDa band was excised, air dried, and stored at -80°C. The N-terminus of the 26 kDa protein was directly sequenced using a gasphase microsequcnccr at the Protein Sequencing Core Facility, Beckman Rcscarch Institute of the City of Hope (Duartc, CA).
Internal amino acid sequence determination
For the 60 kDa protein, the isolated protein spot was excised from 52 Ponceau-Sstained nitroccllulose transfers of Triton X-IOO-insoluble adult rat peripheral nerve proteins that had been separated in two dimensions. The pooled nitroccllulose pieces (containing auproximatelv 5 rg of protein) were incubated with i Fg ofirypsin (scqu&ing grade; Bochrinacr Mannheim) in 100 mM NH..HCO, for 16 hr at 37°C. The rcsultingpcptide fragments were separated by h'igh pressure liquid chromatography, and non-trypsin peaks were subjected to microsequencing. The details of this procedure wcrc exactly as described by Tempst et al. (I 990) . The pcptide sequencing was performed by the Caltech Laboratory of Macromolecular Structure Analysis. For the 26 kDa protein. about IO pg of the ROCA I -affinity-purified peripheral nerve proteins were subjected to SDS-PAGE and transferred to nitrocellulose. After staining with Ponceau-S, to visualize the 26 kDa band, the nitrocellulose was briefly destained with dH,O. The 26 kDa band was then excised and digested with I pg of trypsin (sequencing grade, Boehringer Mannheim) in 100 mM NH,HCO, for I6 hr at 37°C. The remaining steps were identical to those outlined above and described in detail in Tempst ct al. (1990) . In this case, the microsequencing was performed by the Protein Sequencing Core Facility, Beckman Research Institute of the City of Hope (Duarte. CA).
Immunohistochemistry
Tissues dissected from freshly killed adult or postnatal rats were embedded in Tissue-Tek O.C.T. compound (Miles), and frozen on dry ice. Ten micrometer sections were cut using a Bright cryostat (Hacker Instruments, Inc.), placed on gelatin-coated slides, and allowed to air dry for 2 hr. For ROCAI labeling, the sections were washed in phosphatebufFercd saline (PBS: 0.9% NaCI, 0.1 M Na,HPO,, pH 7.4) three times over 15 min, incubated in blocking buffer (PBS containing 3% rat and 3Yo goat serum) for 20 min. incubated in ROCAI hybridoma supcrnatant for 45 min. washed in blocking buffer three times over I5 min, pell.
sup. and washed in blocking buffer three times over 15 min. For the double labeling ofadult dorsal root ganglion (DRG) sections, the first incubation was with ROCAl hybridoma supematant for 1 hr, followed by a wash in PBS for 10 min, an incubation in FITC-conjugated goat anti-mouse IgG secondary antibody (Hi-F) diluted 1:lOO in PBS for 1 hr, and a wash in PBS for 10 min. Sections were then fixed in ice-cold methanol for 10 min, and washed in PBS for 10 min, and incubated in the antiperipherin antiserum (199-2) diluted 1:500 in PBS for 1 hr. This was followed by a wash in PBS for 10 min, an incubation in Texas redconjugated goat anti-mouse IgG secondary antibody (Vector Labs) diluted 1: 100 in PBS, for 1 hr, and a wash in PBS for 10 min. All procedures were carried out at room temperature. In all cases, after the final washing step the slides were mounted in p-phenylenediamine (Sigma), and examined in a Zeiss (ICM 405) inverted fluorescence microscope. Micrographs were generated using Tri-X Pan film.
Results
Identification of the ROCAI and ROCAZ antigens
We previously identified the ROCAl antigen as a 65 kDa protein enriched in membrane/cytoskeletal fractions derived from adult sympathetic ganglia and intercostal nerves (Suzue et al., 1990) . A more extensive analysis of the mobility of this protein on SDS-PAGE, through the use of marker proteins with similar molecular weights, indicates that the more accurate size is 60 kDa (data not shown). To characterize the potential membrane association of this protein, we extracted membrane/cytoskeletal preparations of adult rat sciatic nerves with 1% Triton X-100, and performed immunoblots on the detergent-soluble and -insoluble fractions. The 60 kDa protein is only detectable in the Triton X-1004nsoluble pellet, suggesting that it is not an integral membrane protein, but instead may be a cytoskeletal or extracellular matrix component (Fig. la) . In addition, ROCAl also specifically binds a 26 kDa protein that is present exclusively in the detergent-soluble fraction (Fig. la) . The 60 kDa and 26 kDa proteins are not labeled when ROCAl is omitted from the incubation, nor are they labeled by a variety of other mAbs from the ROCA fusion protocol (data not shown). Thus, it is very likely that the 60 and 26 kDa proteins, which reside in distinct subcellular fractions, share the ROCAl epitope.
We also performed similar immunoblots with ROCA2, a mAb generated in the same fusion, which binds to ganglia and intercostal nerves from all rostra1 and caudal levels equally well. While ROCA2 does not specifically recognize any proteins in the detergent-insoluble fraction, it does strongly bind a 26 kDa protein in the detergent-soluble fraction (Fig. lb) . This finding raised the possibility that ROCAl and ROCA2 recognize the same 26 kDa protein. To test this hypothesis we used ROCAl to immunoprecipitate the 26 kDa protein from 1% Triton X-100 extracts of sciatic nerve membrane/cytoskeletal preparations. Proteins specifically precipitated by ROCA 1 were separated by SDS-PAGE and transferred to nitrocellulose, and an immunoblot analysis was then performed using ROCA2. ROCA2 clearly recognizes the major 26 kDa protein that was immunoprecipitated by ROCAl (Fig. 2) . As described below, the higher-molecular-weight bands observed on this blot are probable glycosylation variants of the 26 kDa protein.
Identijcation of the 60 kDa ROCAI antigen
The Triton X-100 insolubility of the 60 kDa ROCAl antigen hampered immunoaffinity chromatography purification of this Approximately 60 pg of total protein was loaded in each of the gels. Primary antibody binding was visualized with a peroxidase-conjugated goat anti-mouse IgG secondary antibody.
protein. Therefore, we used two-dimensional gel electrophoresis (O'Farrell, 1975) for antigen purification. A Coomassie-stained nitrocellulose transfer of T&on-insoluble adult rat sciatic nerve proteins is shown in Figure 3a . On an identical transfer, ROCAl labels a single 60 kDa spot of protein that migrates with a p1 of about 5.0 (Fig. 3b) . The position of the ROCAl-immunoreactive spot is indicated by an arrow on the transfer stained for total protein, where it is clear that the antigen represents a major T&on-insoluble component. Since the ROCAl spot was well separated from contaminating proteins, and was clearly detectable by Coomassie staining, it seemed likely that multiple, two-dimensional gel electrophoresis runs could be used to obtain significant amounts of the purified protein for amino acid sequencing. The protein spot was excised from 52 Ponceau-S-stained nitrocellulose transfers of Triton X-1 OO-insoluble adult rat sciatic nerve proteins. The nitrocellulose pieces were then digested with trypsin. The resulting peptide fragments were separated by highpressure liquid chromatography, and non-trypsin peaks were subjected to microsequencing by Edman degradation (Tempst et al., 1990) . Four distinct sequences were obtained, each with striking similarity to sequences present in rat peripherin (Leonard et al., 1988) . The sequences of these peptides and the corresponding peripherin residues are aligned in Table 1 .
The identification of the 60 kDa ROCA 1 antigen as peripherin was further demonstrated in two ways. First, we compared the binding of ROCAl and an anti-peripherin antiserum to nitrocellulose transfers of T&on-insoluble adult rat sciatic nerve proteins that had been separated by two-dimensional electrophoresis. The anti-peripherin antiserum binds a spot in the same position as the ROCAl-immunoreactive 60 kDa protein (Fig.  4) . Second, we determined whether ROCAl binds recombinant peripherin on immunoblots. The peripherin fusion protein (obtained from L. Parysek) was generated from a nearly full-length peripherin cDNA insert containing coding sequence for all but the N-terminal 21 amino acids (56 kDa) (Leonard et al., 1988) , plus a portion of the E. co/i trpE open reading frame (37 kDa).
ROCA 1 binds the peripherin fusion protein that migrates with the expected size of 93 kDa (Fig. 5) . This result also indicates that the ROCAl epitope is composed of amino acids, not carbohydrate.
Expression pattern of the ROCAl epitope on peripherin Consistent with the biochemical identification of the 60 kDa ROCAl antigen as peripherin, ROCAl labels the peripherinpositive subpopulation of neurons in sections of early postnatal DRG (Fig. 6a,b) . The small-diameter neurons that strongly express peripherin are identified using the anti-peripherin antiserum on serial sections (Fig. 6b) . As previously reported for adult sympathetic ganglia (Suzue et al., 1990) , however, ROCAl does not label peripherin-positive neurons in sections of adult DRG (Fig. 6c,d) . Instead, as in the adult sympathetic ganglia sections, ROCAl labeling appears to be localized outside and Peptide 4 Peripherin 1 c ml z ml r Four peptides were generated from the 60 kDa ROCAl antigen and their amino acid sequences were determined as described in the Results and Materials and Methods. Common residues are enclosed by lines and printed in boldface. An X represents a residue whose identity could not be. unambiguously determined. adjacent to the neurons, probably in the satellite (glial) cells of the DRG (Fig. 6~ ). Immunoblot analysis of membraneicytoskeletal fractions derived from early postnatal and adult DRG with the anti-peripherin antiserum and ROCAl demonstrates the presence of peripherin, as well as the ROCAl epitope on peripherin in both young and mature DRG (data not shown). Thus, the ROCAl epitope on peripherin is, in fact, present in mature DRG and sympathetic neurons but is not immunohistochemically accessible. Previous immunoblot analysis demonstrated that the ROCA 1 epitope on the 60 kDa protein is expressed in a rostrocaudal gradient in intercostal nerves (Suzue et al., 1990) . Having identified the 60 kDa ROCAl antigen as peripherin, we next asked whether the peripherin protein itself is also distributed in a rostrocaudal gradient using the anti-peripherin antiserum. Membrane/cytoskeletal fractions of adult rat intercostal nerves taken from segments T2-T12 were prepared as previously described (Suzue et al., 1990) . Equal amounts of protein from each of the nerve preparations were separated by SDS-PAGE and transferred to nitrocellulose. To document the rostrocaudal distribution of peripherin, an immunoblot analysis was then performed using ROCAl and the anti-peripherin antiserum. mAbs specific for NF-M and MBP were used as measures of neuronal cytoskeletal proteins and myelin, respectively. As previously reported (Suzue et al., 1990) , the binding of ROCA 1 is highest in the rostra1 segments and declines in a graded manner in the more caudal segments relative to NF-M and MBP (Fig. 7) . The rostr&audal difference between levels T2 + 3 and T 12 for ROCA 1 binding, normalized to MBP or NF-M, is about fourfold (Fig.  7) . The binding of the anti-peripherin antiserum is also highest in the rostra1 segments. The rostrocaudal difference for the antiserum binding is not as pronounced as with ROCA 1, however; anti-peripherin antiserum binding, normalized to MBP or NF-M, is only about twofold greater for T2+3 than for T12 (Fig.  7) . The levels of MBP and NF-M show no obvious rostrocaudal differences (Fig. 7) . These results indicate that the peripherin protein is expressed at higher levels in extreme rostra1 versus extreme caudal intercostal nerves. Moreover, the rostrocaudal difference in ROCAl binding to a rostra1 intercostal nerve, T4, and the sciatic nerve, normalized to MBP and NF-M, is about sixfold, while it is about threefold for the anti-peripherin antiserum (data not shown).
Expression of the ROCAI and ROCAZ epitopes on the 26 kDa protein The ROCAl antigen, distributed in a dramatic rostrocaudal gradient as visualized by immunohistochemical labeling ofadult peripheral nerves and ganglia, is likely to be a surface membrane protein, not a neuronal cytoskeletal component (Suzue et al., 1990) . Thus, although peripherin displays rostrocaudal differences, it cannot be the antigen visualized in sections of peripheral nerves and ganglia. Moreover, the complete solubilization with 1% Triton X-100 of the 26 kDa protein antigen from membrane/cytoskeletal fractions of adult rat peripheral nerves is consistent with the 26 kDa protein being the antigen visualized in immunohistochemistry of adult nerves and ganglia. In addition, we compared the tissue distribution ofthe 26 kDa protein determined by immunoblotting with the immunohistochemical distribution, and find an excellent correlation (Table 2) . A key point is that ROCA 1 stains sections of adrenal chromaffin cells, epithelial cells in the esophagus, and myelin tracts in the cerebellum, where the 26 kDa, but not the 60 kDa antigen, is found. Thus, the 26 kDa protein is very likely the membrane antigen visualized in sections of adult sympathetic ganglia and intercostal nerves.
We also analyzed the rostrocaudal distribution of the 26 kDa protein. Equal amounts of the membrane/cytoskeletal preparations (derived from intercostal nerves T2+3 through T12) used to generate the immunoblot presented in Figure 7a were separated into Triton X-1 OO-soluble and -insoluble components. Equivalent amounts of detergent-soluble protein from each of the nerve preparations were subjected to SDS-PAGE and transferred to nitrocellulose. Immunoblot analysis with ROCA 1 and ROCA2 fails to show significant rostrocaudal differences in the levels of the 26 kDa protein (Fig. 8 ). The result with ROCA2 is consistent with the lack of an immunohistochemical gradient of this epitope (Suzue et al., 1990) . The absence of a detectable rostrocaudal gradient of the ROCAl epitope on the 26 kDa protein is not, however, consistent with the immunohistochemical distribution of this epitope (Suzue et al., 1990) . Thus, it seems likely that the rostrocaudal gradient observed with ROCAl on tissue sections is not due to enhanced expression of the 26 kDa antigen in rostra1 nerves. As in the case for the immunohistochemical gradient of the 43 kDa protein in the retina, the ROCA 1 gradient in intercostal nerves may be due to a preferential masking of the ROCA 1 epitope on this antigen in sections of caudal nerves.
Ident$catlon of the 26 kDa protein ROCA 1 immunoaffinity chromatography was used to purify the 26 kDa protein from extracts of adult rat sciatic nerve. Silverstained gels of a small amount of the column eluate indicate the purity of the preparation (Fig. 9) . In addition to the major 26 kDa protein, minor bands migrating at 30 kDa and 24 kDa are also present. It is very likely that the latter two bands are related to the 26 kDa protein, as they are both detected by ROCA2 in immunoblots, and the size of the 30 kDa protein is reduced to 26 kDa after ENDO-F digestion (data not shown). Large amounts of two independently purified preparations were separated by SDS-PAGE and transferred to Immobilon membranes. The Coomassie-stained 26 kDa bands were excised and subjected to microsequencing by Edman degradation. The following consensus N-terminal sequence was obtained: XVKGGIDEVFYLLF This sequence is very similar to that of the protein termed CD9 isolated from human platelets (Higashihara et al., 1990; Boucheix et al., 1991; Lanza et al., 1991) :
PVKGGTKCIKYLLF
The identity at each end of this sequence (underlined) suggests that the ROCA 26 kDa antigen is either the rat homolog of human CD9, or that it is a nervous system variant ofthis protein.
We also obtained internal sequence information from this purified ROCAl antigen. Approximately 10 Kg of the ROCA laffinity-purified 26 kDa protein was subjected to SDS-PAGE, transferred to nitrocellulose, and stained with Ponceau-S. The 26 kDa band was then excised and exhaustively digested with trypsin. The resultingpeptide fragments were separated by HPLC, T2+3  T4  T6  T8  TlO  T12 Spinal Level Figure 7 . Peripherin is expressed in a rostrocaudal gradient in adult rat intercostal nerves. Membrane/cytoskeletal fractions of adult rat intercostal nerves taken from various segmental levels were subjected to SDS-PAGE and transferred to nitrocellulose. The nitrocellulose transfers were then cut into three pieces representing different molecular weight ranges, and an immunoblot analysis was performed as described in Materials and and non-trypsin peaks were subjected to microsequencing by Edman degradation. The following internal amino acid sequence was obtained:
ELQEFY K Except for the second residue, this sequence is identical to one present immediately adjacent to a trypsin cleavage site in human CD9 (Bouchiex et al., 1991; Lanza et al., 1991) :
This sequence further supports the probable identification of the ROCA 26 kDa protein as a CD9 homolog.
Discussion
In an effort to identify surface molecules that define position in the mammalian nervous system, we generated a mAb, ROCA 1, that defines two rostrocaudal gradients: (I) a 60 kDa ROCAl antigen that is expressed at higher levels in rostra1 than in caudal intercostal nerves, as detected by immunoblot analysis, and (2) a 26 kDa ROCAI antigen that is labeled more strongly in rostra1 than in caudal glial cells, as detected immunohistochemically (Suzue et al., 1990) . We show here that two structurally distinct antigens, the cytoskeletal protein pcripherin and a probable rat homolog of the leukocyte/platelet surface protein CD9, very likely share the ROCAI epitope. While peripherin is expressed in a shallow rostrocaudal gradient, it is the ROCAl cpitope on CD9, and not the protein itself, that is preferentially localized in rostra1 nerves and ganglia. We generated another antibody in the same fusion, ROCAZ, that labels the same cells in ganglia and nerves as ROCA 1, but not in a position-selective manner (Suzue ct al., 1990) . Surprisingly, the rat CD9 homolog identified here also bears the ROCAZ epitope.
Peripherin
Peripherin is a 57 kDa, type III, intermediate filament protein (Leonard et al., 1988; Landon ct al., 1989) . The size and Triton X-100 insolubility of the 60 kDa ROCAl antigen are consistent with it being the cytoskeletal component peripherin. Moreover, ROCA 1 stains peripheral but not central neurons in sections ofneonatal rat tissues. Three additional lines of evidence identify the 60 kDa ROCAI antigen as rat peripherin. First, four internal amino acid sequences derived from the purified protein (see Table 1 ) exhibit high homology with rat peripherin sequences (Leonard et al., 1988) . Second, an antiserum specific for peripherin binds a single major protein that migrates at the same position as the ROCAl-immunoreactive spot in two-dimensional immunoblots of membrane/cytoskeleta1 fractions derived from adult rat sciatic nerves. This further suggests that ROCAl binds the most abundant peripherin isoform. Two alternatively spliced forms of peripherin are known to be expressed at much lower levels and migrate differently in Triton-soluble and -insoluble fractions derived from various adult and neonatal rat tissues were prepared as described in Materials and Methods. Immunoblot analysis ofTriton-soluble and -insoluble fractions with RDCA 1 was used to screen for binding to the 26 kDa protein, and the 60 kDa protein, respectively. Cryosextions were also generated from the same tissues and processed with ROCAI two-dimensional SDS-PAGE than the major form (Landon et al., 1989) . Third, ROCA I binds a bacteria1 fusion protein generated from a peripherin cDNA. This further demonstrates that the ROCAl epitope is composed of amino acids and not carbohydrate.
The initial characterization of ROCAl binding by immunoblot analysis suggested that the 60 kDa protein was preferentially expressed in rostra1 versus caudal intercostal nerves (Suzue et al., 1990) . The enhanced binding of an antiserum specific for pcripherin to rostra1 nerves, on similar immunoblots, supports this result. Although the difference in antiserum binding between extreme rostra1 and caudal levels is not as pronounced as with ROCA 1, both reagents can be used to define rostrocaudal position. This is further supported by the dcmonstration that pcripherin levels, as determined by immunoblot analysis with ROCAl and the anti-peripherin antiserum, are higher in rostra1 intercostal nerves than in sciatic nerve. The present results extend those of Suzue et al. (1990) T2+3  T4  T6  T8 TlO  T12  T2+3  T4  T6  T8 TlO  T12 Spinal Level Spinal Level Figure 8 . The 26 kDa protein is not expressed in a rostrocaudal gradient in adult rat intercostal nerves. Triton X-lOO-soluble fractions derived from equal amounts of the membrane/cytoskeletal preparations used in Figure 7a were subjected to SDS-PAGE and immunoblot analysis. As shown in Figure 7a (Suzue et al., 1990) . fleet a rostrocaudal gradient of cytoskeletal versus myelin protein expression.
The finding that peripherin expression is enhanced in rostra1 nerves extends results from other systems demonstrating position-specific expression of peripherin and particular epitopes on NF-M. For example, transcripts of the Xenopus peripherin homolog XIF3 are enriched in the anterior over the posterior early embryonic nervous system (Sharpe et al., 1989) . In the retinotectal system, a phosphorylated epitope on NF-M undergoes a complex temporal and spatial regulation during ganglion cell axon outgrowth and synapse formation (Go et al., 1989) .
Another recently characterized phosphorylated epitope on NF-M is expressed preferentially in the most distal portion of motor axons in the chick embryo. This epitope is labeled by a mAb at a particular time in development when each group of motor axons is known to respond to guidance cues that lead them to their appropriate muscles (Landmesser and Swain, 1992) . These findings suggest that intermediate filament gene expression may be position specific as well as cell type specific.
Unlike other type III family members (glial fibrillary acidic protein, desmin, and vimentin), peripherin is exclusively expressed in neurons, and predominantly in the PNS (Portier et al., 1984; Leonard et al., 1988; Escurat et al., 1990) . In contrast to the type IV neurofilament triplet proteins, however, peripherin is not expressed in all peripheral neurons. Immunofluorescence labeling of adult rat sciatic nerve sections with peripherin-specific antisera indicates that peripherin is enriched in small-caliber axons (Parysek et al., 199 1) . Peripherin is also enriched in smalldiameter DRG neurons Escurat et al., 1990; Ferri et al., 1990; Goldstein et al., 1991) . ROCAl also strongly labels the cytoplasm of small-diameter, peripherinpositive neurons in sections of DRG taken from early postnatal rats (Fig. 7a) , but the intensity of this staining declines with development, so that ROCAl fails to label peripherin-positive neurons in sections taken from adult animals. We suggest that the ROCAl epitope on peripherin is progressively masked in situ during development, apparently by a noncovalent interaction with another molecule. It seems unlikely that a posttranslational modification of the protein directly masks this ep-itope since it is composed of amino acids, and ROCA 1 continues to bind the 60 kDa band on immunoblots of adult DRG proteins. Developmentally and spatially regulated epitope masking, potentially through protein-protein interactions, has been observed in other systems. For example, an immunohistochemical study has shown that antibody staining of the NILE protein is downregulated in maturing nerves, while Northern and immunoblots demonstrate continued, high-level NILE expression into adulthood (Prince et al., 199 1) . More relevant to the present study, a mAb (22/l@ that likely recognizes an intermediate filament protein specifically labels blastemal cells in sections of regenerating newt limbs, but reacts with a much wider range of tissues on immunoblots (Ferretti and Brockes, 1990) . It is believed that 22/ 18 detects a specific protein conformation that occurs transiently during regeneration and possibly during development (Ferretti and Brockes, 1990) . In support of this, treatment of sections with the fixative ethylene glycol bissuccinimide (EGS), but not with paraformaldehyde, reveals the antigen in sections of normal and regenerating limbs in a distribution consistent with the one detected on the immunoblots (Ferretti and Brockes, 1990 ). Both fixatives cross-link proteins, but the reactive groups in EGS are spaced farther apart than those of paraformaldehyde. Interestingly, treatment of embryonic retina sections with EGS removes the pronounced dorsoventral asymmetry observed immunohistochemically on unfixed or paraformaldehyde-fixed sections with a number of mAbs (see below; Rabacchi et al., 1990) .
kDdCD9
Despite the compelling evidence that peripherin is a ROCAl antigen, immunohistochemical characterization of ROCA 1 binding in sections of adult peripheral nerves and ganglia is inconsistent with the known distribution of peripherin. Most conspicuously, ROCA 1 stains glia -Schwann cells in nerves and satellite cells as well as Schwann cells in ganglia (Suzue et al., 1990) . In addition, ROCA 1 strongly labels myelin tracts in the cerebellum, chromaffin cells in the adrenal medulla, and a variety of epithelial cells (present results; S. Tole and P. H. Patterson, unpublished observations). The cell surface localization of the ROCAl epitope may also be inconsistent with peripherin being the antigen detected immunohistochemically (Suzue et al., 1990; Tole and Patterson, unpublished observations) . On the other hand, the Triton X-100 solubility of the 26 kDa ROCA 1 antigen, and its tissue distribution as detected by immunoblot analysis strongly suggest that it is the protein detected immunohistochemically in adult tissues. This ROCAl antigen was not present at sufficiently high concentrations in the membrane cytoskeletal fractions to be detected along with peripherin in our previous analysis (Suzue et al., 1990) . The fact that ROCAZ labels the same tissues and cell types as ROCAl, and that it binds the ROCA 1 -affinity-purified 26 kDa protein, further supports the identification of this protein as the adult ROCA-glial surface antigen detected immunohistochemically.
Based on N-terminal and internal amino acid sequence data from the affinity-purified 26 kDa protein, we have tentatively identified this ROCAl antigen as the rat homolog of human CD9. CD9 is a major transmembrane protein that has been recently purified from human platelets (Higashihara et al., 1990; Boucheix et al., 1991; Lanza et al., 1991) and whose primary structure has been elucidated by cDNA cloning (Boucheix et al., 1991; Lanza et al., 1991) . The human CD9 protein exists in SILVER STAIN fi26kO Figure 9 . ROCAl immunoalhnity purification of the 26 kDa protein.
A small amount of ROCAl-affinity-purified protein from adult rat peripheral nerves (see Materials and Methods) was subjected to SDS-PAGE and silver staining. This purification yields a major protein at 26 kDa and two minor components at 30 and 24 kDa. three forms ranging in molecular weight between 22 and 27 kDa (Kersey et al., 198 1; Newman et al., 1982; Boucheix et al., 1983; LeBien et al., 1985; Seehafer et al., 1988) . This is consistent with ROCAl affinity column eluates containing three proteins with a similar molecular weight distribution. As in humans, the middle-molecular-weight form is the most abundant in rat, and the three forms are related, since ROCA2 binds each on immunoblots (LeBien et al., 1985 ; data not shown). In addition, ROCAl and ROCAZ each bind a major 26 kDa Triton X-1 OOsoluble protein in extracts of rat platelets (data not shown). These results all support the probable identification of the 26 kDa ROCA antigen as a CD9 homolog. Interestingly, three N-terminal sequencing runs have yielded a consensus sequence with a string of five amino acids that does not match the corresponding human CD9 residues. This may represent a ratspecific or a tissue-specific sequence. cDNA cloning of rat mRNAs should answer this question.
Human CD9 is abundantly expressed on the surface of developing B-lymphocytes, platelets, eosinophils, basophils, and stimulated T-lymphocytes, and has also been detected in a variety of nonhematopoietic tissues (Kersey et al., 198 1; Jones et al., 1982; Boucheix et al., 1987; Boucheix and Benoit, 1988; Von dem Borne et al., 1989) . Two studies have used immunological methods to detect CD9 expression in certain human neuroblastoma cell lines (Kemshead et al., 1982; Komada et al., 1983) , but in vivo expression of CD9 in the nervous system has not been previously described. A number of perturbation studies have suggested a function for this molecule. mAbs against human CD9 specifically induce homotypic adhesion of pre-B lymphocytes (Masellis-Smith et al., 1990) . In platelets, such antibodies induce activation and aggregation, leading to what is termed an adherent phenotype (Jennings et al., 1990; Griffith et al., 199 1) . This activation also induces an association between CD9 and the GPIIb-IIIa integrin (Slupsky et al., 1989) . That this CD9-integrin complex is involved in platelet aggregation is supported by the finding that platelets from patients with Glanzman's thrombasthenia, which lack this integrin but not CD9, are not activated by anti-CD9 antibodies (Boucheix et al., and Patterson -Markers of Rostrocaudal Position i n the Nervous System 1983; Higashihara et al., 1985; Miller et al., 1986) . In addition, anti-CD9 antibodies augment neutrophil adherence to endothelial cells, probably due to an adhesion-promoting activation event within the endothelial cell (Forsyth, 199 1). Taken together, these studies suggest a role for CD9 in the signaling involved in the adhesion and activation of blood cells mediated by intercellular cues. CD9 may participate in this function in association with molecules that directly mediate adhesion (e.g., integrins) (Slupsky ct al., 1989; Masellis-Smith et al., 1990; Forsyth, 199 1) . It is logical to ask whether CD9 is involved in adhesion and signaling in the nervous system as well. In addition to Schwann cell surfaces, CD9 is expressed on neuronal surfaces (Tole and Patterson, unpublished observations). Therefore, this protein could play a role in triggering or mediating homo-or heterotypic adhesion among Schwann cells and neurons. Since most mAbs specific for human CD9 arc directed against functional cpitopes (Boucheix and Benoit, 1988; Griffith et al., 199 l) , we are currently using ROCA 1 and ROCAZ in in vitro perturbation studies.
Gradients by dlxerential antigen expression and epitope masking ROCAl staining is highest in adult, rostra1 intercostal ncrvcs and declines in a graded manner in the caudal segments (Suzue et al., 1990) . Nonetheless, ROCAl lab& the 26 kDa (CD9 homolog) protein uniformly along the rostrocaudal axis on immunoblots. We suggest, therefore, that the ROCAl epitope on CD9 is preferentially masked in situ in caudal nerves, probably as a result of a noncovalent interaction with another protein.
The masking protein, which by analogy with the hematopoietic system could be an integrin, would thus be preferentially cxprcsscd in the caudal nerves. In contrast to the results with ROCAl, the binding of ROCAZ to intercostal nerves detected immunohistochemically is consistent with the binding dctcctcd by immunoblot analysis. By either technique, ROCAZ binding does not reveal a rostrocaudal gradient ofCD9. The results with ROCAZ independently confirm that the CD9 protein itself is not prcfcrcntially expressed in rostra1 versus caudal nerves. This situation is analogous to that of the cxprcssion of a 43 kDa protein in the developing rat retina (McCaffery et al., 1990; Rabacchi et al., 1990) . Multiple mAbs immunohistochemically detect a pronounced dorsoventral gradient, while the protein and corresponding mRNA are expressed at equivalent levels in dorsal and ventral retina halves. Thus, it is possible that epitopc masking can define position in the adult PNS, as well as in the developing retina. These results emphasize the unique ability of the mAb approach to detect positional differences that are not reflected in expression of the gene for the antigen. A subtractive hybridization cDNA approach, for example, would not have identified CD9 in a search for positional differences.
It is striking that peripherin and CD9 each defne rostrocaudal position in the mammalian nervous system and also share the ROCAl epitope. Since peripherin is a cytoskeletal component and CD9 is a transmembrane protein, it seems unlikely that the shared epitope reflects a large degree of structural similarity between the two proteins. In fact, alignment of rat periphcrin and human CD9 protein sequences does not reveal any significant stretches of identity. A definitive comparison will have to await acquisition of the entire rat sequence, however.
A natural question raised by this study is what regulates the position-specific expression of pcripherin and the putative masking of CD9? One possibility is that periphcrin and the putative CD9-masking protein are downstream targets of HOX genes or analogous regulators of position. Interestingly, the peripherin promoter region contains an HOX 1.3 binding motif (F. Landon and M.-M. Portier, unpublished observations) , and the chromosomal location of the mouse and human peripherin genes is very near the HOX 3.0 gene complex (Moncla et al., 1992) . In addition, as demonstrated by in situ hybridization, the expression of the HOX 1.1, I .2, 1.3, and 3. I genes is concentrated in the thoracic region of mouse embryos (Holland and Hogan, 1988; Dressier and Gruss, 1989) . All four genes arc expressed in mesoderm-related as well as ectoderm-derived tissues, such as the neural tube and spinal ganglia. Of particular intcrcst is the expression of HOX 3. I, which is restricted to caudal thoracic segments T6- TlO (Drcssler and Gruss, 1989) . Since this region-specific pattern of expression persists in newborn mice, HOX 3.1 is a candidate for regulating the expression of proteins like the ones under study here.
Note added in proof We have recently isolated several full-length cDNA clones using PCR with primers representing protein sequences derived from the purified 26 kDa protein and cDNA templatesgenerated from adult rat sciatic nerve and superior cervical ganglion RNA. These clones each display 90% identity (at the amino acid level) with human CD9, and each contain the same string of seven amino acids corresponding to one of the tryptic peptides generated from the purified 26 kDa protein, as well as these N-terminal 14 amino acids: PVKGGSKCIKYLLF.
The latter sequence is essentially identical to that found within human CD9, and quite similar to the N-terminal sequence derived from the purified 26 kDa protein. The difference between the N-terminal sequence translated from the nucleotide sequence present in the cDNAs and that derived from the protein suggests that another, alternatively spliced, form of CD9 may exist. These cloning data confirm that Cd9 is present in the rat nervous system, and support the identification of the 26 kDa antigen as CD9.
